| Current Price | $74.70 | Mkt Cap | $3.3B |
|---|---|---|---|
| Open | $74.10 | P/E Ratio | -180.63 |
| Prev. Close | $73.68 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $74.10 - $75.68 | Volume | 83,689 |
| 52-Wk Range | $46.11 - $125.17 | Avg. Daily Vol. | 446,033 |
The Company is a provider of medication control and patient safety solutions for acute care health facilities.
| Current Price | $74.70 | Mkt Cap | $3.3B |
|---|---|---|---|
| Open | $74.10 | P/E Ratio | -180.63 |
| Prev. Close | $73.68 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $74.10 - $75.68 | Volume | 83,689 |
| 52-Wk Range | $46.11 - $125.17 | Avg. Daily Vol. | 446,033 |
The best Bull and Bear pitches based on recency and number of recommendations.
yea, the owner of this company has like 9 kids. he's pretty cool. i think this a good company. seanmcb doesn't know s h i t. he's my 13 year old brother
I am a registered nurse who has used Omnicell machines. I hate them. In my opinion, they are a pain in the butt and they slow down my job. When I am rushing to get an item during surgery, the last thing I want to do is swipe my I.D. card, swipe the… More
Read the most recent pitches from players about OMCL.
Recs
rknapton
(32.29)
Submitted: 8/22/2013 4:48:21 PM :
Start Price:
$22.55
NASDAQ:OMCL Score:
+79.63
Long. Great growth story. Revs up 24% last quarter, earnings up 337%. Trading at 36x ttm earnings and 19x fye estimates so pricey but deservedly so for the growth.
Recs
jimbendt
(26.05)
Submitted: 4/10/2010 2:42:37 AM :
Start Price:
$13.96
NASDAQ:OMCL Score:
+185.23
Can OMCL flourish in a super managed care environment?
Recs
Kinzo
(99.83)
Submitted: 4/3/2009 4:33:15 PM :
Start Price:
$7.90
NASDAQ:OMCL Score:
+438.38
Finally a solution for a doctor's poor handwriting! Get it automated! In all seriousness however, my best friend's grandfather died after receiving the wrong medication while in the hospital. Having OMCL's medication-management products may have prevented such a terrible thing from happening.
Although they aren't the biggest player in the market (Pyxis is), they are still gobbling up market share since they are ahead of the technology curve. Also, by specializing in medication-management products only, this allows the entire company to focus on its product. Oh and requiring 12-18 month software upgrades is nice too (for additional recurring revenues).
Find the members with the highest scoring picks in OMCL.
Peterhaze (< 20) Score: +517.27
The Score Leader is the player with the highest score across all their picks in OMCL.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Peterhaze | < 20 | 1/22/2009 |
|
3Y | $7.27 | +930.88% | +413.61% | +517.27 | 0 Comment | |
| Kinzo | 99.83 | 4/6/2009 |
|
5Y | $7.90 | +848.67% | +410.29% | +438.38 | 1 Comment | |
| bmoneyman | < 20 | 2/4/2009 |
|
3Y | $8.15 | +819.57% | +408.13% | +411.44 | 0 Comment | |
| go4amiller | < 20 | 10/23/2008 |
|
3Y | $8.58 | +773.48% | +377.26% | +396.22 | 1 Comment | |
| GUESSER2 | < 20 | 4/16/2009 |
|
3M | $8.63 | +768.42% | +397.81% | +370.62 | 0 Comment | |
| tjensen3618 | 31.34 | 4/24/2009 |
|
3Y | $8.75 | +756.51% | +390.56% | +365.95 | 0 Comment | |
| issac25 | 93.10 | 4/24/2008 |
|
NS | $11.04 | +578.85% | +213.89% | +364.96 | 0 Comment | |
| pocestnik | < 20 | 4/25/2008 |
|
NS | $11.06 | +577.62% | +213.01% | +364.61 | 0 Comment | |
| groot2000 | 88.51 | 10/30/2009 |
|
3Y | $9.84 | +661.64% | +299.26% | +362.38 | 0 Comment | |
| healthcareinvest | < 20 | 4/24/2008 |
|
3M | $11.06 | +577.62% | +218.05% | +359.57 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
